{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Strachan DP"],"funding":["International Union Against Tuberculosis and Lung Disease","European Research Council","Medical Research Council","National Institute for Health Research (NIHR)","Wellcome Trust"],"pagination":["e13656"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9012331"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["33(1)"],"pubmed_abstract":["<h4>Background</h4>The Global Asthma Network (GAN), by using the International Study of Asthma and Allergies in Childhood (ISAAC) methodology, has updated trends in prevalence of symptoms of childhood allergic diseases, including non-infective rhinitis and conjunctivitis ('rhinoconjunctivitis'), which is reported here.<h4>Methods</h4>Prevalence and severity of rhinoconjunctivitis were assessed by questionnaire among schoolchildren in GAN Phase I and ISAAC Phase I and III surveys 15-23 years apart. Absolute rates of change in prevalence were estimated for each centre and modelled by multi-level linear regression to compare trends by age group, time period and per capita national income.<h4>Results</h4>Twenty-seven GAN centres in 14 countries surveyed 74,361 13- to 14-year-olds ('adolescents"],"journal":["Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology"],"pubmed_title":["Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children: Global Asthma Network Phase I."],"pmcid":["PMC9012331"],"funding_grant_id":["16/136/35","MR/N013638/1","668954"],"pubmed_authors":["Merida-Palacio JV","Chopra K","Bissell K","Hanumante NM","Nour M","Kumar L","El Sony A","Morales E","Sabir M","Asher MI","Marks GB","Aguilar P","Perez-Fernandez V","Shah J","Ellwood P","Soto-Quiros ME","Del-Rio-Navarro BE","Mohammad Y","Silverwood RJ","Mallol J","Chiang CY","Singh M","Mohammad S","Martinez-Torres A","Gratziou CH","Singh V","Navarrete-Rodriguez EM","Ellwood E","Sharma SK","Zar HJ","Eleuterio Gonzalez J","Dib G","Linares-Zapien FJ","Rutter CE","Salvi S","Hsieh KH","Cortez E","Pearce N","Lopez-Silvarrey Varela A","Soto-Martinez M","Garcia-Marcos L","Robertson S","Garcia-Almaraz R","Sanchez JF","Musa O","Rubio AD","Chinratanapisit S","Aguirre V","Gonzalez Diaz C","Kabra SK","Huang JL","Baeza-Bacab M","Onadeko BO","Sukumaran TU","Strachan DP","Gonzalez-Diaz SN","Falade A","Barba S","Global Asthma Network Phase I Study Group","Mortimer K","Awasthi S","Vichyanond P"],"additional_accession":[]},"is_claimable":false,"name":"Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children: Global Asthma Network Phase I.","description":"<h4>Background</h4>The Global Asthma Network (GAN), by using the International Study of Asthma and Allergies in Childhood (ISAAC) methodology, has updated trends in prevalence of symptoms of childhood allergic diseases, including non-infective rhinitis and conjunctivitis ('rhinoconjunctivitis'), which is reported here.<h4>Methods</h4>Prevalence and severity of rhinoconjunctivitis were assessed by questionnaire among schoolchildren in GAN Phase I and ISAAC Phase I and III surveys 15-23 years apart. Absolute rates of change in prevalence were estimated for each centre and modelled by multi-level linear regression to compare trends by age group, time period and per capita national income.<h4>Results</h4>Twenty-seven GAN centres in 14 countries surveyed 74,361 13- to 14-year-olds ('adolescents","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Jan","modification":"2026-03-17T15:51:19.563Z","creation":"2025-02-19T03:41:55.681Z"},"accession":"S-EPMC9012331","cross_references":{"pubmed":["34453861"],"doi":["10.1111/pai.13656"]}}